Dulaglutide (Trulicity) Dulaglutide, marketed as Trulicity formulated as a fusion protein
Ganta says she considers her patients specific health profiles before prescribing GLP-1s, especially with older adults who have frailty, dementia, or another geriatric syndrome
From a medical perspective, these questions cannot be separated from broader issues such as dosing safety, individual tolerance, and long-term risk
Storage method and period of stock solution: -80C, 2 years
Weight regain after stopping GLP-1 drugs may plateau after time, researchers say Although people appear to regain weight rapidly after taking GLP-1 weight-loss drugs this may plateau after time, a new modelling study has reported